Your browser doesn't support javascript.
loading
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
Hosseinipour, Mina C; Bisson, Gregory P; Miyahara, Sachiko; Sun, Xin; Moses, Agnes; Riviere, Cynthia; Kirui, Fredrick K; Badal-Faesen, Sharlaa; Lagat, David; Nyirenda, Mulinda; Naidoo, Kogieleum; Hakim, James; Mugyenyi, Peter; Henostroza, German; Leger, Paul D; Lama, Javier R; Mohapi, Lerato; Alave, Jorge; Mave, Vidya; Veloso, Valdilea G; Pillay, Sandy; Kumarasamy, Nagalingeswaran; Bao, Jing; Hogg, Evelyn; Jones, Lynne; Zolopa, Andrew; Kumwenda, Johnstone; Gupta, Amita.
Afiliação
  • Hosseinipour MC; UNC Project, Lilongwe, Malawi; University of North Carolina School of Medicine, Chapel Hill, NC, USA. Electronic address: mina_hosseinipour@med.unc.edu.
  • Bisson GP; Perelman School of Medicine at the University of Pennsylvania, PA, USA.
  • Miyahara S; Harvard University, Boston, MA, USA.
  • Sun X; Harvard University, Boston, MA, USA.
  • Moses A; UNC Project, Lilongwe, Malawi.
  • Riviere C; GHESKIO, Port-au-Prince, Haiti.
  • Kirui FK; Kenya Medical Research Institute, Kisumu, Kenya.
  • Badal-Faesen S; Clinical HIV Research Unit, Department of Medicine, University of Witwatersrand, Johannesburg, South Africa.
  • Lagat D; Moi University School of Medicine, Eldoret, Kenya.
  • Nyirenda M; Johns Hopkins Project, Blantyre, Malawi.
  • Naidoo K; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Hakim J; University of Zimbabwe, Harare, Zimbabwe.
  • Mugyenyi P; Joint Clinical Research Centre, Kampala, Uganda.
  • Henostroza G; Centre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
  • Leger PD; GHESKIO, Port-au-Prince, Haiti.
  • Lama JR; Asociacion Civil Impacta Salud y Educacion, Lima, Peru.
  • Mohapi L; Perinatal HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa.
  • Alave J; Asociacion Civil Impacta Salud y Educacion, Lima, Peru.
  • Mave V; BJ Medical College-Johns Hopkins Clinical Trials Unit, Pune, India.
  • Veloso VG; Evandro Chagas National Institute of Infectious Diseases/Fiocruz, Rio de Janeiro, Brazil.
  • Pillay S; Durban International CRS, Durban University of Technology, Durban, South Africa.
  • Kumarasamy N; YRGCARE Medical Centre, VHS, Chennai, India.
  • Bao J; HJF-DAIDS, a Division of The Henry M Jackson Foundation for the Advancement of Military Medicine, Contractor to National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Hogg E; Social and Scientific Systems, Silver Spring, MD, USA.
  • Jones L; Frontier Science, Buffalo, NY, USA.
  • Zolopa A; Stanford University, Palo Alto, CA, USA.
  • Kumwenda J; Johns Hopkins Project, Blantyre, Malawi.
  • Gupta A; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Lancet ; 387(10024): 1198-209, 2016 Mar 19.
Article em En | MEDLINE | ID: mdl-27025337
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções Oportunistas Relacionadas com a AIDS / Fármacos Anti-HIV / Isoniazida / Antituberculosos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções Oportunistas Relacionadas com a AIDS / Fármacos Anti-HIV / Isoniazida / Antituberculosos Idioma: En Ano de publicação: 2016 Tipo de documento: Article